Following consultation with the Therapeutic Goods Administration, Roche Pharmaceuticals is undertaking a sponsor initiated recall of all batches and presentations of Viracept (Nelfinavir).
HIV Health Project
All sorts of things can directly and indirectly affect the health and wellbeing of people with HIV — from the prompt availability of new treatments, to the way that medicines are funded or doctors are paid for their services at a national level. The HIV Health Project provides high-level policy advice and advocacy across a broad spectrum of national issues affecting the health of people living with HIV and AIDS.
Major areas of the Project include:
- Negotiating with pharmaceutical industry to secure and expedite access to important new and emerging HIV treatments.
- Working with doctors and HIV researchers to develop research programs and design trial protocols which reflect the specific health needs of people with HIV/AIDS.
- Providing comment and advice to government on national health care policies and systems, such as Medicare, the PBS and the drug regulatory system, and their likely effects on people with HIV.
- Working together with other health care consumer groups on relevant national health policy issues.
- Assisting and advising on the education and information materials for HIV-positive people.
The Health Policy Project works in conjunction with NAPWA’s Health and Treatments Portfolio.
Viracept (Nelfinavir) being withdrawn in Australia
12 June 2007 - 10:57am
Following consultation with the Therapeutic Goods Administration, Roche Pharmaceuticals is undertaking a sponsor initiated recall of all batches and presentations of Viracept (Nelfinavir).
Advice on T-20 and international travel
1 September 2006 - 9:50am
Following the recent terrorist alert in the UK, new rules prevent passengers on many international flights carrying liquids in their hand luggage. Read this article for advice on travelling with T-20 under the new rules. PREParing the facts
11 October 2005 - 12:14pm
Kirsty Machon questions the misinformation, controversy and conspiracy theories which put an end to the proposed PREP trials among sex workers in Cambodia and Cameroon.
A response to 'World Without AIDS'
11 October 2005 - 11:52am
A response to the book World Without AIDS (Phillip Day and Steven Ransom, Credence Publications, 2000).
Relative merit: keeping the HIV research program real
11 October 2005 - 11:41am
A paper presented at the 2005 ASHM Conference by NAPWA’s HIV Health Policy Analyst, Kirsty Machon. Positive women’s views on routine HIV antenatal screening
11 October 2005 - 11:10am
A poster presentation from the 2005 ASHM Conference held in Hobart, Tasmania.
Budget blow
From the April 2005 issue of Positive Living
People living with HIV/AIDS are among the big losers in the 2005/06 federal budget handed down by treasurer Peter Costello on May 10. NAPWA submission to NHMRC review
16 March 2005 - 12:00am
The National Health and Medical Research Council (NHMRC) is currently undertaking a review of the National Statement on Ethical Conduct in Research Involving Humans (1999), an important document that identifies the ethical principles which apply to medical and other research in Australia. NAPWA has made submission to the review.
Washington lipodystrophy conference
14 December 2004 - 12:00am
The Sixth International Workshop on Lipodystrophy and Adverse Events was held in Washington DC, USA, from 25 to 28 October 2004. NAPWA’s HIV Health Policy Officer, Kirsty Machon, attended the workshop and has filed a detailed report.
Rewriting the script for a healthy PBS
From the October 2003 issue of Positive Living
p(standfirst). 
A government advertising campaign has drawn criticism and reignited the debate over future funding of the Pharmaceutical Benefits Scheme.
A government advertising campaign has drawn criticism and reignited the debate over future funding of the Pharmaceutical Benefits Scheme.